A carregar...
Acute Interstitial Lung Disease Induced by Rechallenge with Ceritinib
A 40-year-old Japanese man with advanced pulmonary adenocarcinoma harboring anaplastic lymphoma kinase (ALK)-rearranged was administered the selective ALK inhibitor ceritinib as a third-line treatment and continued treatment for nine months. After fourth-line treatment, we performed rechallenge with...
Na minha lista:
| Publicado no: | Intern Med |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The Japanese Society of Internal Medicine
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7008039/ https://ncbi.nlm.nih.gov/pubmed/31534079 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.2597-18 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|